• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Acentra Health Names New Senior Vice Presidents, Mohamed Karama and Nirav Dalal, to Drive Company Growth and Business Development

    3/25/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance
    Get the next $CG alert in real time by email

    MCLEAN, Va., March 25, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced today that Mohamed Karama has joined the company as Senior Vice President of Growth Acceleration and Performance, and Nirav Dalal has been promoted to Senior Vice President of Sales Leadership. These appointments advance Acentra Health's transformation initiatives and position the company for strategic growth.

    "As we continue transforming Acentra Health, we're investing in our growth engine," said Patty Obermaier, EVP, Chief Growth Officer, Acentra Health. "These talented leaders will help us build on our trusted relationships and growth momentum to meet the needs of our clients and the broader market, today and into the future."

    As Senior Vice President of Growth Acceleration and Performance, Karama will be responsible for strengthening cross-functional execution and accelerating strong revenue growth across Acentra Health. He has over 25 years of global executive leadership experience across healthcare, government, financial services, and technology-enabled organizations. Throughout his career, he has driven sustained revenue growth, led digital transformation initiatives, and established governance and performance frameworks that strengthened organizational accountability and results.

    Most recently, Karama served as a senior strategist and board member across multiple organizations, advising leadership teams on enterprise growth strategy, go-to-market execution, and governance excellence. He previously held senior leadership roles at Guidehouse, advising the Centers for Disease Control and Prevention (CDC) on IT strategy and governance; served as a partner at PwC leading advisory practices across Eastern Africa, with significant growth impact; and led U.S. federal healthcare consulting portfolios at Unisys, supporting the U.S. Department of Health and Human Services (HHS) and the Department of Veterans Affairs.

    "I am thrilled to join Acentra Health during such an exciting growth period and am inspired by the company's mission to innovate solutions that accelerate better health outcomes," said Karama. "I look forward to joining the team to advance clarity and growth acceleration through sales excellence, market development, data-driven decision-making, and strategic partnerships."

    Karama holds a bachelor's degree in accounting from the University of Maryland. He currently serves as a board member of Safe Routes Partnerships in Virginia, a nonprofit that champions safe walking and rolling to and from schools and in everyday life, boosting health and strengthening communities. He also serves as a board member of Global Good x Amani, an organization offering innovative solutions for social impact worldwide.

    As Senior Vice President of Sales Leadership, Dalal will lead Acentra Health's expanded business development and capture management functions. He joined the company in August 2024 as Vice President of Capture Management, bringing 25 years of sales, information technology, and public sector experience to clients across the country.

    "I am excited for this new leadership opportunity at Acentra Health," said Dalal. "Since I joined the company over a year and a half ago, I've been extremely impressed with the dedication of our team members as we work to bring value to our clients and the populations they serve. I look forward to partnering with Acentra Health leaders in this next phase of growth."

    Prior to joining Acentra Health, Dalal held senior leadership roles at Optum, IBM, and Hewlett-Packard (HP) Enterprise, serving a variety of clients, including Medicaid agencies. He established sales governance structures and developed data-driven pricing approaches that led to multimillion-dollar deals and a 75%-win rate. He has also led delivery and client relationship teams, including managing operational functions such as customer service; provider enrollment; and fraud, waste, and abuse prevention.

    Dalal holds a bachelor's in management science and information systems from Penn State University and an MBA from Washington State University. He serves as Chair of the Inclusion and Multicultural Engagement Advisory Committee for Hood to Coast, a company dedicated to creating world-class endurance races and events that inspire connection, encourage movement, and celebrate the power of community.

    About Acentra Health

    Acentra Health combines public sector knowledge, clinical expertise, and technological ingenuity to modernize the healthcare experience for state, federal, and commercial partners, and their priority populations. From designing and developing advanced claims, encounter, and provider solutions that drive efficiency and cost savings to delivering clinically focused solution models for care management, clinical assessments, and quality oversight, Acentra Health is accelerating better health outcomes. Acentra Health is backed by Carlyle (NASDAQ:CG), a global investment firm. Learn more at acentra.com. 

    Acentra Health Media Contacts:

    Marnie Keogh

    Senior Vice President, Marketing

    Acentra Health

    703-214-3666

    [email protected]

    Lindsey Rodarmer

    Public Relations Manager

    Acentra Health

    240-404-9090

    [email protected]

    Photos accompanying this announcement are available at:

    https://www.globenewswire.com/NewsRoom/AttachmentNg/dbcf47c1-fbbc-4b0f-b844-e56774128a07 

    https://www.globenewswire.com/NewsRoom/AttachmentNg/336cccfe-fbb3-45c6-bd65-a01e0db5bcb7



    Primary Logo

    Get the next $CG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CG

    DatePrice TargetRatingAnalyst
    2/24/2026$67.00Outperform
    RBC Capital Mkts
    12/11/2025$74.00Buy
    UBS
    10/3/2025$74.00Outperform
    BMO Capital Markets
    7/10/2025$65.00Neutral → Buy
    Citigroup
    5/14/2025$56.00Hold → Buy
    TD Cowen
    3/19/2025Outperform → Perform
    Oppenheimer
    1/3/2025$60.00Peer Perform → Outperform
    Wolfe Research
    9/12/2024$42.00Equal Weight
    Wells Fargo
    More analyst ratings

    $CG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on Carlyle Group with a new price target

    RBC Capital Mkts initiated coverage of Carlyle Group with a rating of Outperform and set a new price target of $67.00

    2/24/26 7:47:48 AM ET
    $CG
    Investment Managers
    Finance

    UBS resumed coverage on Carlyle Group with a new price target

    UBS resumed coverage of Carlyle Group with a rating of Buy and set a new price target of $74.00

    12/11/25 9:06:22 AM ET
    $CG
    Investment Managers
    Finance

    BMO Capital Markets initiated coverage on Carlyle Group with a new price target

    BMO Capital Markets initiated coverage of Carlyle Group with a rating of Outperform and set a new price target of $74.00

    10/3/25 8:37:30 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Carlyle to Announce First Quarter 2026 Financial Results and Host Investor Conference Call

    WASHINGTON and NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- The Carlyle Group Inc. (NASDAQ:CG) announced today that it will release financial results for the first quarter 2026 on Thursday, May 7, 2026, and host a conference call at 8:30 a.m. EDT. The conference call will be available via public webcast from the Events & Presentations section of ir.carlyle.com and a replay will also be available after the call's completion. Chief Executive Officer Harvey Schwartz, along with Chief Financial Officer Justin Plouffe and Head of Public Investor Relations Daniel Harris, will review the results during the call. The earnings release will be available through all Carlyle channels, including the

    4/9/26 10:05:31 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Named to Newsweek's Greatest Workplaces for Entry Level 2026 List

    MCLEAN, Va., April 08, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced it has been named to Newsweek's "America's Greatest Workplaces for Entry Level" 2026, a prestigious recognition honoring organizations that excel in supporting employees at the start of their careers. The award, presented by Newsweek in partnership with Plant-A Insights Group, is based on one of the largest independent workforce studies in the U.S. The ranking evaluates companies with more than 1,000 employees using a combination of a large-scale natio

    4/8/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle to Acquire Majority Stake in MAI Capital Management

    The new investment strengthens MAI's capital base, supports advisors, and provides continuity for clients and teams MAI Capital Management ("MAI"), a registered investment advisor ("RIA") focused on empowering clients to simplify, protect, and grow their wealth, today announced that it has signed an agreement for funds managed by global investment firm Carlyle (NASDAQ:CG) to acquire a majority stake in the company, valuing it at more than $2.8 billion. Carlyle initially invested in MAI in 2021 through its investment in Galway Holdings, which acquired MAI that year, and will become the majority owner upon closing, with Galway Holdings, funds managed by Harvest Partners, LP ("Harvest Partne

    3/31/26 7:30:00 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by The Carlyle Group Inc.

    SCHEDULE 13G/A - Carlyle Group Inc. (0001527166) (Subject)

    3/26/26 4:44:46 PM ET
    $CG
    Investment Managers
    Finance

    SEC Form 10-K filed by The Carlyle Group Inc.

    10-K - Carlyle Group Inc. (0001527166) (Filer)

    2/27/26 4:13:57 PM ET
    $CG
    Investment Managers
    Finance

    The Carlyle Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Carlyle Group Inc. (0001527166) (Filer)

    2/26/26 7:00:39 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Rubenstein David M.

    4 - Carlyle Group Inc. (0001527166) (Issuer)

    3/20/26 5:34:13 PM ET
    $CG
    Investment Managers
    Finance

    Large owner Carlyle Group Inc. sold $1,070,339,440 worth of shares (26,105,840 units at $41.00) and disposed of 2,113,483 shares (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Reporting)

    3/12/26 4:30:20 PM ET
    $CG
    Investment Managers
    Finance

    Large owner Carlyle Group Inc. converted options into 9,297,883 shares and disposed of 9,297,883 units of Class B Common Stock (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Reporting)

    3/6/26 7:02:25 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    Financials

    Live finance-specific insights

    View All

    Carlyle to Announce First Quarter 2026 Financial Results and Host Investor Conference Call

    WASHINGTON and NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- The Carlyle Group Inc. (NASDAQ:CG) announced today that it will release financial results for the first quarter 2026 on Thursday, May 7, 2026, and host a conference call at 8:30 a.m. EDT. The conference call will be available via public webcast from the Events & Presentations section of ir.carlyle.com and a replay will also be available after the call's completion. Chief Executive Officer Harvey Schwartz, along with Chief Financial Officer Justin Plouffe and Head of Public Investor Relations Daniel Harris, will review the results during the call. The earnings release will be available through all Carlyle channels, including the

    4/9/26 10:05:31 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Presents Growth Outlook at 2026 Shareholder Update

    WASHINGTON and NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) is announcing its growth outlook and financial objectives at the 2026 Shareholder Update, beginning today at 8:30 a.m. EST. The program will include presentations by senior leadership, followed by a Q&A session. Carlyle will announce three-year financial targets to be achieved by the end of 2028, including: FRE of $1.9+ billionInflows of $200+ billionDE per common share of $6.00+ Carlyle is also announcing that its Board of Directors has approved a new $2 billion share repurchase authorization. The authorization provides the firm with flexibility to repurchase shares as part of its disc

    2/26/26 7:01:00 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Secured Lending, Inc. Announces Financial Results For Fourth Quarter and Full Year Ended December 31, 2025, Declares First Quarter 2026 Dividend of $0.40 Per Common Share

    NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD) today announced its financial results for its fourth quarter and full year ended December 31, 2025. Alex Chi, CGBD's Chief Executive Officer, said, "As CGBD's newly appointed CEO, I look forward to continuing to build on Carlyle's strong track record and world-class platform. Building off record origination volume in the fourth quarter and full year 2025, we continue to expand our origination apparatus and are focused on further harnessing the full power of the OneCarlyle platform. The depth of our underwriting se

    2/24/26 4:05:00 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    $CG
    Leadership Updates

    Live Leadership Updates

    View All

    Acentra Health Names New Senior Vice Presidents, Mohamed Karama and Nirav Dalal, to Drive Company Growth and Business Development

    MCLEAN, Va., March 25, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced today that Mohamed Karama has joined the company as Senior Vice President of Growth Acceleration and Performance, and Nirav Dalal has been promoted to Senior Vice President of Sales Leadership. These appointments advance Acentra Health's transformation initiatives and position the company for strategic growth. "As we continue transforming Acentra Health, we're investing in our growth engine," said Patty Obermaier, EVP, Chief Growth Offic

    3/25/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle to Host 2026 Shareholder Update

    WASHINGTON and NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) announced today that it will host a Shareholder Update on Thursday, February 26, 2026. The Shareholder Update will include a series of presentations by the company's senior leadership team and will review Carlyle's growth outlook and financial objectives. Presentations will begin at 8:30 a.m. EST, followed by a Q&A session. Presentation materials and a live webcast will be posted on the day of the event and can be accessed on the Events & Presentations section of ir.carlyle.com. For those unable to join the live webcast, a replay will be available on the website following the event. Any

    2/2/26 8:01:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Appoints Balajee Sethuraman as Executive Vice President and Chief Business Services Officer

    MCLEAN, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Balajee Sethuraman as Executive Vice President and Chief Business Services Officer (CBSO), where he will lead the company's business services and delivery operations. This strategic addition to Acentra Health's executive leadership team supports its ongoing efforts to streamline and strengthen enterprise-wide delivery through a unified operating model. "Balajee is a transformative leader with exceptional experience scaling global team

    1/27/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

    11/15/24 5:22:29 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/21/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/15/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance